Similar articles

• Carcinoma of the corpus uteri.

  Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Sideri M, Pecorelli S. Creasman WT, et al. J Epidemiol Biostat. 2001;6(1):47-86. J Epidemiol Biostat. 2001. PMID: 11385776 No abstract available.
• Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

  Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Clinical Trial.
• [Super radical surgery of advanced ovarian cancers (stages III and IV)].

  Michel G, Castaigne D, Morice P, Lhommé C, Duviliard P. Michel G, et al. Contracept Fertil Sex. 1997 Jun;25(6):V-XI. Contracept Fertil Sex. 1997. PMID: 9280543 French. No abstract available.
• [Ovarian carcinoma--diagnosis and treatment. Consensus conference of the National Institute of Health].

  Bornkessel B. Bornkessel B. Med Monatsschr Pharm. 1995 Oct;18(10):292-6. Med Monatsschr Pharm. 1995. PMID: 7476655 Review. German. No abstract available.
• Recent advances in the management of women with ovarian cancer.

  Eltabbakh GH. Eltabbakh GH. Minerva Ginecol. 2004 Feb;56(1):81-9. Minerva Ginecol. 2004. PMID: 14973412 Review.